Group 1 - Alpha Cognition Inc. (ACOG) is a stock in the Medical sector, which includes 950 individual stocks and has a Zacks Sector Rank of 4 [2] - ACOG currently holds a Zacks Rank of 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] - Over the past three months, the Zacks Consensus Estimate for ACOG's full-year earnings has increased by 30%, reflecting improved analyst sentiment [4] Group 2 - Year-to-date, ACOG has returned approximately 8.2%, outperforming the average gain of 6.5% for Medical stocks [4] - ACOG belongs to the Medical - Biomedical and Genetics industry, which consists of 467 stocks and is currently ranked 91 in the Zacks Industry Rank [6] - Stocks in the Medical - Biomedical and Genetics industry have gained an average of 19.9% this year, indicating that ACOG is slightly underperforming its industry [6] Group 3 - Actinium Pharmaceuticals (ATNM) is another Medical stock that has outperformed the sector with a year-to-date increase of 15.1% [5] - The consensus estimate for Actinium Pharmaceuticals' current year EPS has risen by 11.7% over the past three months, and it also holds a Zacks Rank of 2 (Buy) [5] - The Medical - Drugs industry, to which Actinium Pharmaceuticals belongs, has moved up by 7.9% this year and is currently ranked 79 [7]
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?